tm
Seeing Is Believing
tm
Seeing Is Believing
AKRO is currently covered by 8 analysts with an average price target of $71.5. This is a potential upside of $25.96 (57%) from yesterday's end of day stock price of $45.54.
Akero Therapeutics's activity chart (see below) currently has 41 price targets and 73 ratings on display. The stock rating distribution of AKRO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 60.28% with an average time for these price targets to be met of 343.33 days.
Highest price target for AKRO is $109, Lowest price target is $38, average price target is $71.5.
Most recent stock forecast was given by ELIANA MERLE from UBS on 31-Jan-2025. First documented stock forecast 15-Jul-2019.
Currently out of the existing stock ratings of AKRO, 42 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$109
$59.88 (121.91%)
$42
1 months ago
(31-Jan-2025)
2/4 (50%)
$54.92 (101.55%)
401
Buy
$73
$23.88 (48.62%)
$56
1 months 3 days ago
(28-Jan-2025)
5/8 (62.5%)
$21.53 (41.83%)
450
Buy
$96
$46.88 (95.44%)
$46
1 months 3 days ago
(28-Jan-2025)
3/6 (50%)
$44.53 (86.52%)
350
Buy
$72
$22.88 (46.58%)
$50
1 months 4 days ago
(27-Jan-2025)
12/24 (50%)
$20.29 (39.24%)
266
Buy
8 months 11 days ago
(20-Jun-2024)
1/4 (25%)
$29.93 (96.33%)
474
What is AKRO (Akero Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AKRO (Akero Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?
Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?
Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?
